LATEST

• REGULATORY Japan Tightens Oversight of Mounjaro Resales: Health Minister
  June 8, 2026

• BUSINESS Kaken Files Head Lice Treatment in Japan
  June 8, 2026

• BUSINESS UCB Japan Seeks Pediatric Use, Dry Syrup Approval for Briviact
  June 8, 2026

• BUSINESS Nobelpharma’s Nobelzin Makes China Debut for Wilson Disease
  June 8, 2026

• BUSINESS Japan Ethical Drug Sales Rise 7.3% in April: Crecon
  June 8, 2026

• ACADEMIA Japan Cancer Center Lowers Recommended BMI Ceiling for Men to 25
  June 5, 2026

• BUSINESS Eisai to Raise 50 Billion Yen via Bond Issue for R&D, Licensing
  June 5, 2026

• BUSINESS Japan Market for Fertility, Contraception, Female Disorders Put at 228.5 Billion Yen by FY2035
  June 5, 2026

• BUSINESS Toho, DHL Partner on Healthcare Logistics Platform
  June 5, 2026

• REGULATORY LDP Panel Finalizes Honebuto Proposal on Preventive Care, Adds Obesity Focus
  June 5, 2026

• BUSINESS Keytruda Maintains Lead as Japan’s Top-Selling Drug for 32nd Month: Encise
  June 5, 2026

• REGULATORY Ex-GSK Japan Head Calls for End to "Obsolete" 14-Day Prescription Limit
  June 5, 2026

• REGULATORY Trazenta Generic Outlook Remains Clouded as Court Upholds Treatment-Method Patents
  June 4, 2026

• BUSINESS Boehringer’s Japan Pharma Sales Up for 7th Straight Year, 10-Plus Launches Eyed by 2030
  June 4, 2026

• BUSINESS Sato Bets on Solo Nailin Promotion, Hospital Push to Drive Dermatology Growth
  June 4, 2026

• REGULATORY LDP Generic Caucus Wants Swift Disclosure of Company Indicator Ratings
  June 4, 2026

• BUSINESS Nitrosamine Detected in Viatris’ Jzoloft OD Tablets
  June 4, 2026

• BUSINESS RaQualia, RIKEN Team Up on Drug Discovery Technologies
  June 4, 2026

• ORGANIZATION Time Ripe for Debate on Drug Spending Macroeconomic Indexing: INES
  June 3, 2026

• BUSINESS AbbVie Japan Says Sales-Doubling Plan on Track as Revenue Climbs 13.5%
  June 3, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• Next ›
• 最終 »